Counterfeit Ozempic diabetes medication in circulation
6 octobre 2023 – The latest generation of diabetes medication is currently in great demand as it can also cause weight loss. Due to high demand, counterfeits are increasingly appearing on the market. At the end of last week, the Regional Council of Freiburg im Breisgau announced that counterfeit packs of manufacturer Novo Nordisk’s Ozempic pens are currently in circulation in Germany. Their use poses a high risk to health.
For more information, see here.